Dr. Reinhard Gabathuler, biOasis Technologies Inc., Vancouver, Canada

elopment of a new peptide vector Transcend (melanotransferrin) for brain delivery of therapies for the treatment of brain diseases
Start Date 14.03.2012 - 17:00
Event End 14.03.2012 - 17:00
Location Universität Basel, Pharmazentrum
elopment of a new peptide vector Transcend (melanotransferrin) for brain delivery of therapies for the treatment of brain diseases